Shares of Ainos, Inc. (OTCMKTS:AIMD – Get Free Report) dropped 1.1% on Friday . The company traded as low as $2.76 and last traded at $2.77. Approximately 80,225 shares traded hands during mid-day trading, a decline of 14% from the average daily volume of 93,494 shares. The stock had previously closed at $2.80.
Ainos Stock Down 1.1%
The company has a quick ratio of 1.45, a current ratio of 1.92 and a debt-to-equity ratio of 0.08. The stock has a market cap of $11.61 million, a price-to-earnings ratio of -3.18 and a beta of 2.13. The business’s fifty day moving average is $1.29 and its two-hundred day moving average is $0.82.
About Ainos
Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.
Featured Articles
- Five stocks we like better than Ainos
- Why is the Ex-Dividend Date Significant to Investors?
- Why Pure Storage Is a Core Investment for the AI Era
- The 3 Best Fintech Stocks to Buy Now
- 2025: A Pivotal Year for Smart Glasses As Meta Invests in Ray-Ban
- How to Use Stock Screeners to Find Stocks
- Unity’s New Ad Solutions Drive Stock to 52-Week High
Receive News & Ratings for Ainos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ainos and related companies with MarketBeat.com's FREE daily email newsletter.
